Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Lemoyneon Jan 28, 2021 4:41pm
161 Views
Post# 32413819

RE:RE:RE:RE:RE:RE:SNDL is going to push all POT stocks higher today

RE:RE:RE:RE:RE:RE:SNDL is going to push all POT stocks higher todayI thought intl news would porbably come out when stada shipments were done and be news that would group multiple aspects rear (Q4) and forward looking (Stada/Q1 2021). Stada shipments should happen in february so news could come out in second half of Q1.

Maybe CFO announcement coming soon as we are 2.5 months since search began.

You can google CannabiStada Extrakt (probable brand under which medipharm products will be manufactured for Stada). Tip: Use google translate for german pharmacy websites.

5 strains of flower (Different levels of THC and one equilibrated THC/CBD) and 3 full spectrum oils (THC, CBD and equilibrated) from what I've seen.

Products are still out of stock but this is encouraging as they should be available soon considering they are listed.

If LABS manages increasing revenues/ cleaning its balance sheet for from Q3 to Q1, this could be a decisive turn around and set the table for a good valuation change in 2021.


<< Previous
Bullboard Posts
Next >>